These results suggest a potential cooperative interaction between mutant <i>TERT</i>p and <i>TP53</i> in the pathogenesis of bladder cancer, highlighting their significance as prognostic biomarkers and promising targets for novel therapeutic strategies. The gene discussed is TP53; the disease is urinary bladder carcinoma.